PDF factsheet
      Z

antithrombotics in post myocardial infarction for all type of patients, clinical trials results

dabigatran versus placebo
REDEEM, 2009
NCT00621855
dabigatran 4 dosages (50mg twice daily, 75mg twice daily, 110mg twice daily, 150mg twice daily)
versus
placebo
patients with recent acute coronary syndromes (ST- or non-ST-elevation myocardical infarction)double blind
Follow-up duration: 6 months

  Options


in first

in second

  Filter